82 subjects GFD with oat consumption 54 subjects GFD without oats
2 years
Mean = 24 g/day (minimum 6 months)
Antiavenin IgA, anti-gliadin IgA, and TTG IgA
No biopsy
Not specified
Most adult CD patients can tolerate oats Ingestion of oats does not cause increased levels of IgA oats in CD patients with GFD Purity of oats not verified
Duodenal biopsies before and after oat challenge (Marsh score): histology scores did not significantly change during oat challenge
One relapse occurred in a patient who became noncompliant with GFD
IgA TTG antibodies remained negative in all patients and the histology scores did not change. Support the safety of uncontaminated oats for patients with CD
96 (54%) with persistent IEL 74 (42%) normal small intestinal mucosa 7 (4%) villous atrophy
Mean = 11 years
Not specified
Endomysial IgA and TTG IgA
Consumption of oats was the only factor contributing to the persistent IEL
Despite excellent villous recovery, persistent IEL was common among CD patients on a long-term GFD. Consumption of oats was associated with persistent IEL Purity of oats not verified.
4 subjects did not complete the full 3-day challenge
34 patients reported no symptoms and 46 reported digestive symptoms. Ingestion of 100 g of oats provides weak antigenic stimulation of blood avenin-specific T cells (<10% of CD patients) which is different from the antigenic stimulation observed with wheat, rye, and barley
Abs: antibodies; CD: celiac disease; GFD: gluten-free diet; IEL: intraepithelial lymphocytes; IgA: immunoglobulin A; IgG: immunoglobulin G; TTG: tissue transglutaminase; GFD-std: standard GFD without oats; GFD-oats: GFD with uncontaminated oats.